Step-down of budesonide/formoterol in early stages of asthma treatment leads to insufficient anti-inflammatory effect.
about
Stopping long-acting beta 2 -agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroidsStopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroidsThe Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future useThe US Food and Drug Administration's drug safety recommendations and long-acting beta2-agonist dispensing pattern changes in adult asthma patients: 2003-2012.Stepping down the dose of inhaled corticosteroids for adults with asthma.
P2860
Step-down of budesonide/formoterol in early stages of asthma treatment leads to insufficient anti-inflammatory effect.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Step-down of budesonide/formot ...... ient anti-inflammatory effect.
@en
Step-down of budesonide/formot ...... ient anti-inflammatory effect.
@nl
type
label
Step-down of budesonide/formot ...... ient anti-inflammatory effect.
@en
Step-down of budesonide/formot ...... ient anti-inflammatory effect.
@nl
prefLabel
Step-down of budesonide/formot ...... ient anti-inflammatory effect.
@en
Step-down of budesonide/formot ...... ient anti-inflammatory effect.
@nl
P2093
P2860
P1433
P1476
Step-down of budesonide/formot ...... ient anti-inflammatory effect.
@en
P2093
Hiroki Shimizu
Keiji Mouri
Koji Kurose
Masaaki Abe
Masaki Ikeda
Shigeki Katoh
Yasushi Obase
Yoshihiro Kobashi
Yoshihiro Ohue
P2860
P304
P356
10.3109/02770903.2013.795588
P407
P577
2013-06-18T00:00:00Z